Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Protocol For A Multicentre, Double-Blind, Randomised, Parallel Group Study To Compare The Efficacy and Tolerability Of Celecoxib Vs. Diclofenac In The Treatment Of Subjects With Osteoarthritis Of The Hip Requiring Joint Replacement Therapy

NCT00174317 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00174317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Protocol For A Multicentre, Double-Blind, Randomised, Parallel Group Study To Compare The Efficacy and Tolerability Of Celecoxib Vs. Diclofenac In The Treatment Of Subjects With Osteoarthritis Of The Hip Requiring Joint Replacement Therapy
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2003
Completion date
February 28, 2005
Enrollment
250
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, hip